HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

(2S)-2-Ethoxy-3-{4-[2-(10H-phenoxazin-10-YL)ethoxy]phenyl}propanoic acid

HCID 447458
NotesReactions
Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
222834-30-2
Standard SMILES
CCO[C@@H](Cc1ccc(OCCN2c3ccccc3Oc3ccccc32)cc1)C(=O)O
InChIKey
WMUIIGVAWPWQAW-DEOSSOPVSA-N
Molecular formula
C25H25NO5
Average molar mass
419.5 g/mol
Monoisotopic mass
419.1732729

Names & identifiers

Preferred name
(2S)-2-Ethoxy-3-{4-[2-(10H-phenoxazin-10-YL)ethoxy]phenyl}propanoic acid
IUPAC
(2S)-2-ethoxy-3-[4-(2-phenoxazin-10-ylethoxy)phenyl]propanoic acid
English name
NNC 61-0029
Molecular formula
C25H25NO5
Molecular weight
419.48

Names & synonyms

(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACIDCHEMBL24038NNC-61-0029DRF-2725(alphaS)-alpha-Ethoxy-4-[2-(10H-phenoxazin-10-yl)ethoxy]benzenepropanoic acidUNII-Q5ELR5A7Y51nyxDRF 2725; NN 622(-)-DRF 272(-)-DRF 27252-Ethoxy-3-[4-(2-phenoxazin-10-yl-ethoxy)-phenyl]-propionic acidGTPL2664
Show more names
NNC 61-0029(-)-DRF-2725Benzenepropanoic acid, α-ethoxy-4-[2-(10H-phenoxazin-10-yl)ethoxy]-, (αS)-
orb1699555SCHEMBL4822459(-)-3-(4-(2-(Phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoic acidSCHEMBL29369224(-)-(2S)-2-Ethoxy-3-(4-(2-(10H-phenoxazin-10-yl)ethoxy)phenyl)propanoic acidWMUIIGVAWPWQAW-DEOSSOPVSA-NBDBM50109551AKOS040749270

Database identifiers

CAS
222834-30-2
PubChem CID
447458
ChEMBL
CHEMBL24038

Properties

Computed structural properties

XLogP
5
Topological polar surface area
68.2 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
9
Heavy atoms
31
Formal charge
0
Complexity
542

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Melting point
89 · 89-90 °C
Boiling point
608.6 · 608.6±55.0 °C(Predicted)
Density
1.241 · 1.241±0.06 g/cm3(Predicted)
pka
3.61 · 3.61±0.10(Predicted)
FDA UNII
5 ELR5A7Y5 · Q5ELR5A7Y5

Chemistry & industry

Applications

UsesRagaglitazar is a PPARα and PPARγ agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models. Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic.

Upstream & downstream products

Downstream products

RAGAGLITAZAR

Suppliers6 total

上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
斯派螺(武汉)药物研发有限公司[email protected]
苏州美石生物科技有限公司1173954148q · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
TargetMol中国(陶术生物)15002134094 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]

Related reactions

2 records
New reaction record
HRID 2219781 reaction equation
HRID 2219781As productuspto-grants-2008_08
HRID 2219782 reaction equation
HRID 2219782As reactantuspto-grants-2008_08

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Nikkaji
J1.611.626B